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Purpose: The tumour inhibitor p53 gene has the
ability of triggering proliferation arrest and cellular
death by apoptosis subsequent to several factors,
among them oxidative stress. The p53 protein is a
major regulator of gene expression. Using geneti-
cally manipulated mice carrying an extra copy of
gene p53 (transgenic mice super p53) versus control
mice, we have investigated the generation of reacti-
ve oxygen species and antioxidant activity in the
optic nerve of mice in relation to p53 availability.
Methods: We studied two groups of 12-month-old
mice of the strain C57BL/6: 1) super p53 group
(Sp53) and 2) wild-type control group (CG). Mice
were anesthetized in ether atmosphere and the eye-
ball and retrobulbar optic nerves were excised, was-
hed, soaked in PBS, and stored in liquid nitrogen at
–85ºC until processing. Three-four optic nerves
from the same group were placed in an eppendorf
tube, homogenized and enzymatic-colorimetric
methods used to determine oxidative and antioxi-
dant activities and the nitric oxide synthesis.
ORIGINAL ARTICLE
RESUMEN
Objetivos: El gen supresor tumoral p53 detiene la
proliferación y la muerte celular por apoptosis sub-
secuente a la acción de diversos factores, entre ellos
el estrés oxidativo. La proteína p53 es fundamental-
mente un regulador de la expresión génica. Utili-
zando ratones genéticamente manipulados para pre-
sentar una copia extra del gen p53 (transgénicos
super p53) frente a ratones controles, hemos inves-
tigado el estado oxidativo y antioxidante en los ner-
vios ópticos, en relación a p53.
Método: Se han utilizado ratones de la cepa
C57BL/6 de 12 meses de edad en dos grupos: 1)
grupo super p53 (Sp53) y 2) grupo de controles
wild-type (GC). Los ratones fueron anestesiados en
atmósfera de éter, extrayendo los globos oculares y
nervios ópticos que se lavaron en PBS, mantenien-
do las muestras en nitrógeno líquido y en congela-
dor de –85ºC hasta su procesamiento. Se homoge-
neizaron 3-4 nervios ópticos por cada eppendorf,
clasificando por grupos y determinando mediante
métodos enzimático-colorimétricos la actividad
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INTRODUCTION 
Protein p53 has a molecular weight of 53 kD
(which accounts for its name) and its main charac-
teristic is that it intervenes directly in controlling
the cellular cycle and in the replication and repair of
deoxyribonucleic acid (DNA), maintaining geno-
mic stability, activating apoptosis and participating
in the cellular response to noxious external agents.
Mainly, protein p53 is a regulator of genic expres-
sion, acting as transcription factor capable of acti-
vating or inhibiting specific genes, notably gene
p21, bax and fas, gene IGF-BP3 (insulin-like
growth factor-binding protein-3), genE gadd45
(growth arrest and DNA damage-45) and the cycli-
ne G gene, all of which are involved in the cellular
division cycle and therefore in the proliferation and
apoptosis cycle (1,2). Said functions determine that
the tumor-suppressing protein p53 is related to can-
cer prevention due to its ability to regulate the trans-
formation, proliferation and death of cells in the
presence of a variety of agents, including attacking
nucleic acids and oncogenic stress (1-4). Gene p53
encodes protein p53 and the human genome seems
to include about 200 copies of this gene in chromo-
some 17. 
Damage to DNA can come from exogenous natu-
ral agents (ultra-violet radiations, micro-organisms)
or endogenous (hypoxia, oxidative stress) and also
from chemical agents (drugs, pesticides, preservati-
ves, contaminating gases and the like). Therefore,
how is p53 stimulated after damages against DNA?
It has been proposed that p53 can join the single-
chain DNA and thus localize the injury, or that p53
acts in response to anomalies in nucleotide metabo-
lism (1,2,5). In addition, it has been demonstrated
that protein p53 becomes inactivated when cellular
oxidative activity increases, and for that reason it
has been suggested that protein p53 may act as a
sensing agent for endocellular oxidative stress (5,6)
and that, in biologically favorable situations, there
may be mechanisms for inducing or inhibiting
apoptosis (1,2,7-9).
The above concept is particularly interesting in
ophthalmology because apoptosis, or programmed
cellular death, has been related to a number of pro-
cesses, notably the death of retinal ganglionary cells
in the course of glaucoma (10,11). 
The apoptosis process responds to the activation
of specific mechanisms culminating in the death of
cells (1,2,7-11). The activation of the suicide pro-
gram involves the synthesis of specific messenger
RNA and its corresponding translation, which
demonstrates that cellular death involves intrinsic
intracellular mechanisms (4). In multiple cell types,
said apoptosis process depends on gene p53. In fact,
Results: A significant increase in free radical for-
mation (via lipid peroxidation; p<0.001), antioxi-
dant activity (p<0.001) and nitric oxide synthesis
(p<0.001) was found in the optic nerves from trans-
genic super p53 mice compared to respective con-
trols.
Conclusion: The presence of an extra copy of the
p53 gene correlated with redox status in the mouse
optic nerve. This transgenic mouse could be useful
as an experimental model to study cell resistance to
neurodegenerative processes in relation to oxidative
stress and to apoptosis induction, such as glauco-
matous optic neuropathy or age-related macular
degeneration (Arch Soc Esp Oftalmol 2008; 83:
105-112).
Key words: P53 gene, super p53 mice, oxidative
stress, nitric oxide, optic nerve.
peroxidativa y actividad antioxidante total y la con-
centración de oxido nítrico.
Resultados: Existe aumento significativo en la for-
mación de radicales libres via peroxidación lipídica
(p<0,001), de la actividad antioxidante (p<0,001) y
síntesis de óxido nítrico (p<0,05) en los nervios
ópticos de los ratones transgénicos super p53, fren-
te a los ratones controles.
Conclusiones: La presencia de una copia extra del
gen p53 está ligada a modificaciones de la actividad
redox en el nervio óptico del ratón, sugiriendo que
p53 otorga una mayor resistencia a la agresión oxi-
dativa. Valoramos la utilización de este modelo de
ratón transgénico en procesos neurodegenerativos
relacionados con el estrés oxidativo y la inducción
de la apoptosis, como la neuropatía óptica glauco-
matosa o la degeneración macular asociada a la
edad.
Palabras clave: Gen p53, ratón super p53, estrés
oxidativo, óxido nítrico, nervio óptico.
the activation of protein p53 triggers a complex
transcriptional program which, according to the cell
type and the properties of the environment, leads to
an arrest of the cell cycle or, alternatively, to its
death by apoptosis (7,9). The search for balance
between the mechanisms which promote cell survi-
val and those which initiate self-destruction sequen-
ces is the true goal of many researchers because in-
depth knowledge of these mechanisms can be the
cornerstone for new therapeutic strategies. In this
regard, it has been demonstrated that apoptosis-pro-
moting mutations during the development of the
ocular globe cause congenital malformations, while
those which inhibit apoptosis suppress the appea-
rance of those phenotypes (9,12). 
We endeavor to analyze the properties of protein
p53 in order to understand its function in neurode-
generative eye diseases having unclear etiopathoge-
nic mechanisms, such as glaucomatous optic
atrophy which, due to its morbidity, is an important
cause of irreversible blindness all over the world. In
this study we have utilized an experimental model
in mice, genetically manipulated to have supernu-
merary copies of gene p53 in the form of large
transgenes, obtaining super p53 transgenic mice
(Sp53) (3). 
In addition, as indicated above, as the increase in
oxidative activity is capable of inactivating protein
p53 and that said protein could be a biological mar-
ker of endocellular oxidative stress, regulating at
the same time apoptosis-inducting or inhibiting pro-
cesses in favorable conditions, we aim to make a
biochemical characterization of the optic nerves of
Sp53 mice to investigate whether these animals
exhibit variations as regards the redox activities of
mice with non-modified genotypes.
SUBJECTS, MATERIAL AND
METHOD 
In this study we have utilized mice as experi-
mental models. All experiments complied with
European animal manipulation laws (CE, 1986). 
Characteristics of the experimental model
C57BL6/J, Charles River mice were selected and
genetically manipulated in the National Biotechno-
logy Centre (Madrid) to have two extra copies of
the p53 gene (super p53 tg/tg) as per the method of
García-Cao et al. (3). In order to ensure the useful-
ness of the modified genotype it must be taken into
account that the transgenic allele p53-tg, when pre-
sented in an environment which is genetically neu-
tral for p53, becomes a functional replica of the
endogenous gene. This was the case with the mice
utilized in this study. In addition, the Sp53 mice
having p53-tg alleles in addition to the two endoge-
nous alleles, exhibited a greater response to dama-
ges infringed to the DNA and demonstrated greater
protection against cancer than normal mice (3). 
Therefore, our study was based on the utilization
of the transgenic mice model generated by the use
of large DNA segments containing the p53 gene in
its natural genomic context in order to preserve as
far as possible the characteristics of the gene (3).
The transgenic animal model which over expresses
gene p53 was characterized by polymerase chain
reaction genotyping (PCR) and identification of the
specific strip which corresponds to the supernume-
rary gene. Figure 1 shows a specific strip which
confirms the presence of the additional transgene
p53, containing the p53 promoting region, so that
its regulation is identical to that of the endogenous
p53 gene. 
The functionality of the transgene was demons-
trated in vivo and in vitro. The super p53 mice exhi-
bited normal development, were fertile and aged
normally in comparison to control animals. This
was the case in all the subsequent litters throughout
this study and others carried out with the same
experimental model (3).
Obtention of samples
The animals came from the National Biotechno-
logy Center of Madrid and were kept in standard
laboratory conditions in the CSIC Biomedicine Ins-
titute of Valencia. Eighteen mice aged 12 months
were selected at random for both groups of the
study (GSp53; n=9 vs GC; n=9). These were sacri-
ficed by exposure to ether atmosphere for a few
minutes and the ocular globes and optic nerves
excised. These were frozen in liquid nitrogen and
stored at –85ºC awaiting processing in the labs of
the «Santiago Grisolía» Ophthalmological Rese-
arch Institute of Valencia. The ocular globes were
desiccated, separating the optic nerves which were
homogenized in Eppendorfs, each containing the
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optic nerves and classified according to the study
group. By means of Ultraturrax with pauses to
avoid overheating and over ground ice the nervous
tissue homogenates were obtained. These were uti-
lized in enzymatic-colorimetric techniques to deter-
mine the oxidative and antioxidant condition and to
determine nitric oxide as per techniques described
by other authors in a variety of tissues, albeit with
personal modifications applied to the management
of ophthalmological samples, as extensively descri-
bed in previous works of our group (6-11). Basi-
cally, the oxidate condition was determined by esta-
blishing the end products of lipid peroxidation,
malonildialdehyde (MDA) and the thiobarbituric
acid technique and the products which react with it
(TBARS). The solution containing the homogenate
was boiled for 1 hour and the supernatant extracted
with butanole. A sample (in triplicate) was deposi-
ted in multi-bowl plates for spectral fluorometric
reading in cytofluor at 544 nm excitation and 592
nm emission. The formulae of metabolites which
took part in the enzymatic-colorimetric reaction are
the following: 
The determination of the total antioxidant condi-
tion (TAXC) was established by means of the total
antioxidant capacity of the sample utilizing a speci-
fic combination of reactants which measure the
TAXC activity of the homogenized tissue, which is
marketed by Randox Labs. The end reaction obtains
the measure of the TAXC activity by means of a
spectrophotometer at a wavelength of 600 nm. 
The total nitric acid was determined by means of
a commercial preparation by R&D Systems. This
essay was based on the enzymatic conversion of
nitrate to nitrite by means of nitrate reductase enzy-
me. After the reaction the colorimetric determina-
tion of the nitrite is carried out by Griess’ reaction
which is based on a two-stage diazotization reac-
tion: 1) acidification of NO2 in order to produce a
nitrosating agent and 2) reaction of this agent with
sulphanylic acid to produce a diazonium ion which
will be joined to N-(1-naphthyl) ethylendiamine to
form a chromophore which absorbs light at 540-570
nm, and which is measurable. 
The statistical processing of data was made with
the Excel for Windows v 2003 spreadsheet softwa-
re by Microsoft corporation (USA) and SPSS v 15.0
(Inc. Redmond WA, USA). The groups were com-
pared by the “t for student” test and the Kolmogo-
rov-Smirnov test. All the date are presented as
mean and standard deviation. The confidence inter-
val of the sample was of 95%. 
RESULTS 
The mean determinations of oxidative activity by
means of lipid peroxidation show a significant
increase of the MDA-TBARS values (p<0.001) in
the optic nerves of the Sp53 group vis-à-vis the con-
trol mice (2.2 SD 0.6 vs 1.3 SD 0.2) as shown in
figure 2. 
The mean total antioxidant activity of optic nerve
homogenates was significantly greater [TAXC
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Fig. 1: PCR genotyping of the mice over expressing gene p53.
(p<0.001)] in Sp53 mice than in controls (1.8 SD
0.4 vs 0.7 SD 0.1) as can be seen in figure 3.
The mean determination of nitric oxide synthesis
demonstrated a significant increase of values
(p<0.001) in the optic nerves of the Sp53 group in
relation to the optic nerve values of wild type animals
(143 SD 54 vs 105 SD 39), as can be seen in figure 4. 
DISCUSSION 
By the use of transgenic models a greater know-
ledge can be obtained about genic transmission
mechanisms and cell cycle stages as well as obtai-
ning a fundamental basis for developing therapies
(1,19). The model we present in this study which
contains an extra copy of the gene which encodes
protein p53 allows for an analysis of certain charac-
teristics derived from the functions of this protein
and for a description of variations in relation to the
supernumerary presence of gene p53 (3). 
In the study of the optic nerve of Sp53 mice we
have described an increase in the formation of free
radicals through the lipid peroxidation pathway
(MDA-TBARS) and also the increase of TAXC
capacity and nitric oxide synthesis. These results
prove that the presence of an extra copy of gene p53
confers redox characteristics in the tissue being stu-
died which are different to those observed in ani-
mals with normal genome. In this respect, Lotem et
al (8) have demonstrated that apoptosis induced by
p53 in myeloid leukemia cells can be inhibited by
cytokines IL6, IL3 and interferon g as well as by
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Fig. 2: Determination of MDA TBARS in both groups of
mice. The values (µMol/l) are mean ± standard devia-
tion. Significance was set at 95%. 
Fig. 3: Determination of total antioxidant activity TAXC
in mice. The values (µMol/ml) are mean ± standard
deviation. Significance was set at 95%. 
Fig. 4: NO determination in both groups of mice. The
values (µMol/ml) are mean ± standard deviation. Signi-
ficance was set at 95%. 
antioxidants. In Proceedings of the National Aca-
demy of Sciences, USA, said authors stated that
antioxidants and cytokines exhibit a protective
effect in the induction of apoptosis. It seems that
these cells, which have a high intrinsic level of pro-
duction peroxides and greater sensitivity to apopto-
sis, require a greater concentration of cytokines to
inhibit it. Accordingly, by reducing the oxidative
stress in cells by administering antioxidants, apop-
tosis is inhibited whereas by increasing intrinsic
stress with the addition of hydrogen peroxide, apop-
tosis is stimulated. This would demonstrate that the
intrinsic degree of oxidative stress can regulate
cellular susceptibility to the induction of p53 gene-
dependent apoptosis as suggested previously (3,7-
9). Likewise, from the instant results it can be dedu-
ced that the optic nerves of Sp53 mice there is a gre-
ater oxidative capacity but also a greater antioxidant
activity when compared with the biochemical enzy-
matic-colorimetric results obtained from the optic
nerves of control mice with a normal p53 gene. This
suggests that, in the nerve tissue of the study, the
supernumerary presence of the gene is translated in
an increase of activity of the p53 protein and, bio-
chemically, in a significant increase of antioxidant
defenses of cells against oxidative attack. Therefo-
re, the action of said protein on the optic nerve is
similar to that described in other tissues, regulating
the cellular susceptibility to oxidative stress and
possibly to the induction of apoptosis which
depends on this process. Protein p53 is crucial for
understanding tissue resistance to the formation of
oxygen-reactive species in optic nerves and their
study will shed further light on the ways to counte-
ract redox-dependent apoptosis.
On the other hand, the significant increase of
nitric oxide synthesis in the optic nerves of the Sp53
group matches the results obtained in the aqueous
humor of patients with open angle primary glauco-
ma (20). As glaucoma progresses, the retina gan-
glionary cells receive less neurotrophines. This
mechanism is part of a series of events associated to
high IOP which include ischemia, vascular dys-
function and release of cytokines and molecules
with cytotoxic effects such as glutamate. The main
purpose of neuroprotective therapy is to interrupt
said sequence at one or more points. In fact, Neu-
feld et al of Washington University (20) have
demonstrated that an excess of NO is associated to
increased IOP and other signs of glaucoma, while
an interruption in the synthesis of NO prevents or
delays the evolution of the glaucomatous disease.
The question is: is NO the agent which causes
damage to ganglionary cells or does it appear as a
metabolic product of said damage? It seems that the
mechanism is that NO induces the injury and death
of ganglionary cells independently of the IOP incre-
ase or the control thereof. This is a point to be taken
into account when analyzing the action of existing
anti-glaucoma drugs and also to address anti-glau-
coma therapies in the future. 
NO is a powerful activator of protein p53. Howe-
ver, the mechanisms of this action are not entirely
clear. It seems that NO induces the phosphorylation
of p53 in serine 15, which does not require ATP.
NO induces the nuclear retention of p53 and the
apoptosis of neuroblastoma cells exposed to ioni-
zing radiation (21). This means that, by increasing
NO, the efficacy of radiotherapy for treating certain
types of cancer would be enhanced. In addition, as
it has been demonstrated that p53 plays a crucial
role in the response to mutagenic endogenous mole-
cules such as NO and that human cells exposed the-
reto exhibit an accumulation of p53, it is quite pos-
sible that in order to safeguard the integrity of
DNA, the possibility of NO-induced damage is
reduced by the repression of the p53-mediated syn-
tase-2 nitric oxide enzyme (22). 
The Sp53 experimental model mice exhibited a
greater antioxidant activity in the optic nerves and
therefore it is assumed to have a greater cellular
resistance or potentially different behavior against
oxidative aggression, particularly in conditions of
ischemia-reperfusion or inflammation, and induc-
tion of redox-dependent apoptosis.
Protein p53 is essential for understanding tissue
resistance to the formation of oxygen reactive spe-
cies and the action of nitric oxide on optic nerves,
in relation to neurodegenerative processes such as
glaucomatous optic neuropathy or age-related
macular degeneration.
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